Statistics on the level of assaults and random mandatory drug testing within the prisons taking part in the 10 Prisons Project (MoJ)
Bibliography: All Publications
National intelligence network on drug health harms briefing: August 2019
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (PHE)
Latest UNODC Monitoring Report shows decline of coca cultivation in Bolivia
In 2018, the cultivation of coca crops in Bolivia decreased by six per cent compared to data from 2017, according to the latest Coca Cultivation Survey presented today in La Paz by the United Nations Office on Drugs and Crime (UNODC) and the Government of the Plurinational State of Bolivia
Reports and Detailed Tables From the 2018 National Survey on Drug Use and Health (NSDUH)
Key Substance Use and Mental Health Indicators in the United States (SAMHSA)
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2019 report (PDF)
The aim of the Unlinked Anonymous Monitoring (UAM) Survey of People Who Inject Drugs (PWID) is to monitor the prevalence and incidence of HIV, hepatitis B and hepatitis C infection, and associated injecting risk behaviour in people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines (Public Health England)
Smoking, Drinking and Drug Use among Young People in England 2018 [NS]
This report contains results from a biennial survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15), focusing on smoking, drinking and drug use. It covers a range of topics including prevalence, habits, attitudes, and for the first time in 2018, wellbeing (NHS Digital)
What America’s Users Spend on Illegal Drugs, 2006–2016
This report updates and extends estimates of the number of users, retail expenditures, and amount consumed from 2006 to 2016 for cocaine (including crack), heroin, marijuana, and methamphetamine in the United States, based on a methodology developed by the RAND Corporation for the Office of National Drug Control Policy
Deaths related to drug poisoning in England and Wales: 2018 registrations
Deaths related to drug poisoning in England and Wales from 1993 onwards, by cause of death, sex, age and substances involved in the death (Office of National Statistics, UK)
The cost and consequences of the war on drugs (PDF)
The report’s findings suggest that, from a human rights perspective, there must be a shift from international drug policies that focus on criminalization and supply reduction, to ones that have human rights and health at their core (Human Rights Foundation)
2017-2019 Drug Trend Report
Information about the most commonly used drugs in Scotland, emerging trends and have provided context to the recently released drug-related death statistics – download (Crew)
Middle-aged generation most likely to die by suicide and drug poisoning
Now in their 40s and 50s, the so-called Generation X are dying in greater numbers by suicide or drug poisoning than any other age group (ONS)
Cannabis and Mental Health (PDF)
Priorities for research in Canada (Mentalhealth Commission)
Substance misuse: January to March 2019
Quarterly data are published on StatsWales. These include data on quarterly activity, case closures by reason for closure and the time between referral and start of treatment (Welsh Government)
Urban–rural Differences in Drug Overdose Death Rates, by Sex, Age, and Type of Drugs Involved, 2017
Data from the National Vital Statistics System, Mortality (CDC)
Review of approaches taken in Ireland and in other jurisdictions to simple possession drug offences (PDF)
A report for the Irish Department of Justice & Equality and the Department of Health (and the working group on this issue)
Deaths registered in England and Wales: 2018
Mortality statistics on deaths registered in England and Wales by age-group, sex and underlying cause of death (National Statistics, UK)
Assessing Cannabis Supply and Demand in Washington State
This report provides detailed information about state-legal cannabis production and sales in Washington, as well as insights about the total amount of tetrahydrocannabinol (THC) obtained from legal and illegal sources by Washington residents (RAND)
Latest update on drug-related deaths and mortality in Europe
The information provided in the report is collected through the EMCDDA’s expert network on drug-related deaths (DRD)
Drug related deaths and suicides in prison custody
Analysis of drug-related deaths and suicides in England and Wales, 2008 to 2016 (Office for National Statistics, UK)
Australian NSP Survey National Data Report 2014 – 2018
The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (antibody and RNA) and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia
NIH establishes network to improve opioid addiction treatment in criminal justice settings
Ten clinical research centers will address gaps in accessing high-quality care
Report calls for radical rethink on support given to released prisoners recovering from addiction
A major new report examining the help given to prisoners recovering from addiction has set out a series of “blueprints” which its authors say could “transform” the way prisoners are supported once they have served their sentence (University of York)
Drug-related Deaths in Scotland in 2018
Statistics of drug-related deaths in 2018 and earlier years, broken down by cause of death, selected drugs reported, age and sex (National Records of Scotland)
Trends in Drug-Induced Deaths in Australia, 1997-2017
Each year, the Australian Bureau of Statistics (ABS) makes available to Drug Trends in-depth data on drug-induced deaths in Australia. This year, we have produced a suite of products to summarise trends in drug-induced deaths in Australia from 1997 to 2017 (NDARC)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017 (HRB, Ireland)
Serbia — Early warning system profile
The profile presents the structure, objectives and working methods of the Serbian national early warning system (EMCDDA)
Drugs policy: medicinal cannabis
Contents section (Parliament, UK)
Stronger evidence needed to improve confidence in medicinal cannabis
Despite the rescheduling of medicinal cannabis, very few prescriptions have been issued. One of the many reasons for this is because of the gaps in the evidence base (Parliament, UK)
New psychoactive substances in Australia: Who uses them, how prevalent are they, and where are they sourced?
In this article, NDARC’s Dr Rachel Sutherland provides an in-depth overview of new psychoactive substances (NPS) in Australia that covers what they are, who uses them and which specific NPS are being consumed (NDARC)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Breaking the embargo: a proposal to break UK public health medicinal cannabis impasse (PDF)
Commissioning national clinical assessments of cannabis-based medicinal products in the management of chronic disease (Centre for Medicinal Cannabis)
World Drug Report 2019
Presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history (UNODC)
Classification of Drugs: when science was left behind,
The first-ever comprehensive report providing a political reading of the current evaluation and classification, or “scheduling” of drugs according to their harms (The Global Commission on Drug Policy)
Developments in the European cannabis market
This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to inform a discussion of the new challenges that may emerge in the monitoring of these products and the consequences of their use (EMCDDA)
Hard Edges
The central aim of this study was to establish a statistical profile of the extent and nature of severe and multiple disadvantage (SMD) in Scotland
Report into homelessness and drug misuse published
Safe housing key to tackling homeless drug misuse, says ACMD report
The International Narcotics Control Board on cannabis: A critique of the report for 2018
As can be seen over the past 45 years or so, the potency of the Report has arguably shifted away from the public and more towards influencing opinion within the UN’s central policy-making body on the issue of drugs, the Commission on Narcotic Drugs (IDPC)
Cannabis-based products for medicinal use
In development [GID-NG10124] Expected publication date: 21 October 2019 (NICE)
National Wastewater Drug Monitoring Program
The Australian Criminal Intelligence Commission has commissioned the University of Queensland, and through it the University of South Australia, to undertake the data collection and analysis that underpins the report. This is the seventh in a series of nine public reports
General Report of Activities 2018 – Key achievements and governance: a year in review
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme (EMCDDA)
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 49
- Next Page »
